40 Manning Road
384 articles with Bruker Corporation
Bruker Announces Further Portfolio Expansion for Microbial Identification, Infection Control and Molecular Diagnostics of Infectious Diseases
Reference library expansion for broader species identification by MALDI Biotyper (MBT)
Bruker Announces World's First Superconducting 1.1 Gigahertz Magnet for High-Resolution NMR in Structural Biology
Homogeneous 25.9 Tesla Standard-bore NMR Magnet Sets New World Record
Bruker Corporation announced that it has acquired the semiconductor mask repair and cleaning business of RAVE LLC, a leading provider of nanomachining and laser photomask repair equipment.
Bruker Announces Further Progress in 4D Proteomics and Additional Novel timsTOF Pro™ Workflows at EuPA 2019
New workflows for next-generation 4D metabolomics, leveraging routine, accurate and large-scale collision cross section (CCS) determinations on timsTOF Pro
Bruker Announces Improved Assay for Tuberculosis Diagnostics in Novel Liquid Array™ Format for Improved Multiplexing
Expanded FluoroType™ MTBDR 2.0 Liquid Array molecular assay with CE-IVD mark provides highly differentiated tuberculosis (TB) detection and antibiotic resistance testing
At Pittcon 2019, Bruker this week highlights new and innovative analytical systems and high-value applied market solutions for food analysis, pharma applications, materials science research and quality control, clinical and preclinical research, and advances in scientific software solutions.
Enhanced Focus on Pharma and Biopharma Software and Workflow Solutions
Bruker Corporation (Nasdaq: BRKR) announced financial results for its fourth quarter and fiscal year ended December 31, 2018.
Bruker Corporation announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco.
Bruker Corporation has been advised that former board member, Mr. Joerg C. Laukien, has authorized a block sale of Bruker shares as part of his retirement planning and portfolio diversification.
Bruker Corporation announced that it has completed its previously announced acquisition of Alicona Imaging GmbH, a leading provider of optical-based metrology products in Graz, Austria.
Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications
Bruker Corporation and Mestrelab Research SL today announced that they have entered into a strategic partnership to advance chemistry software that handles spectroscopic data and extracts and manages chemical information from a variety of analytical techniques, including for example NMR and mass spectrometry.
New Luxendo SPIM AIM Provides Adjustable Beam Patterns for Flexible Lattice Light-Sheet or Structured Illumination of Live Samples
ATI and Bruker Announce Agreement to Further Advance Niobium-Based Superconductor Technology and Manufacturing Processes
Agreement to advance state-of-the-art niobium-based superconductors.
Bruker Corporation today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock.
New Ultima 2Pplus Delivers Most Advanced and Versatile 3D Photostimulation and Full-Field Imaging for Neurobiology
New Luxendo MuVi SPIM CS Combines Light-Sheet Fluorescence Microscopy and Tissue Clearing Techniques
Bruker Corporation today announced financial results for its third quarter and nine months ended September 30, 2018.
Bruker Launches the S2 POLAR™ High-Performance, Multi-Element Benchtop EDXRF Analyzer for the Petrochemical Industry
he S2 POLAR offers the same excellent analytical precision for quality control in the petrochemical industry
Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH
Acquisition expands Bruker's Microbiology & Diagnostics business with profitable Molecular Diagnostics portfolio and substantial innovation pipeline